Chief Commercial Officer · Guardant Health, Inc. · Guardant Health, Inc. — Stock Option (Right to Buy)
Side
M
Value
—
Shares
24.4K
Price
—
Executed
May 22, 2026
Disclosed
May 26, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
May 22 executedMay 26, 2026 disclosed
GH · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 11 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Guardant Health, Inc. — Stock Option (Right to Buy)
Ticker
GH
Shares
24.4K
Price per share
$0
Execution date (reported)
May 22, 2026
Owned after transaction
701 shares
Days from execution to publication
4
What this establishes
Freeman Chris filed this Form 4 reporting a option exercise of GH on May 22, 2026. It became public on May 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial Officer
Freeman Chriscik:0001871615
Issuer
Guardant Health, Inc.cik:0001576280
Revision history · 0
No field has changed since this record was first ingested.
